D-Risk Investing Podcast

Walmart ($WMT): Is the unstoppable retail titan defying financial gravity? While the macro environment, AI innovation (like the new OpenAI partnership), and nearly unanimous analyst "Buy" ratings scream bullish, our valuation models reveal a colossal canyon, suggesting the stock is trading far above its fundamental worth. The crowd is clearly buying the hype, with virtually no one betting against the stock, but the price chart is hinting that this powerful rally is running on fumes. Tune into D-Risk as we dissect the classic battle between overwhelming market momentum and a stark overvaluation, and find out what technical breakdown could send the retail giant tumbling from its high-flying price.

Is a government lifeline a golden ticket or just a gilded cage? We're diving into the explosive battle for D-Wave Quantum ($QBTS), the quantum computing stock seeing its future priced on a headline. Yesterday's news of potential U.S. government equity stakes sent the stock soaring, clashing with the cold reality of a cash-intensive business and a chart that's flashing major technical warning signs of a broken rally. With unanimous analyst 'Buys' squaring off against a massive short interest and institutional selling, this is a high-stakes tug-of-war. Tune in to D-Risk to dissect the fundamental catalyst against the bearish technicals and discover whether the sugar rush of speculative news can overcome the severe damage on the chart, we give you our verdict on whether to hold, fold, or double down.

Is it possible to deliver a record number of cars and still see profits plummet by a staggering 37%? That's the Tesla ($TSLA) paradox we're unraveling, right after the Q3 earnings shocker. We dive into the ultimate conflict: a sky-high valuation ($438 stock vs. fair value estimates as low as $44!) clashing with a powerful story of Cybercabs and innovation. We decode the surprising optimism in the options market versus the quiet warning signs in the stock's fading technical momentum. Tune in to discover the key battleground price points—from the after-hours low to critical resistance at $445—and get our no-nonsense strategic outlook and the exact invalidation level that determines if the bulls or the bears win this battle of hype versus hard numbers.

When quantum computing pioneer IonQ drops a "world-record" bombshell, is the stock finally licensed to ignore its dismal financials? Tune into D-Risk as we cut through the noise on a stock that's a classic battleground: a visionary, world-changing story clashing with a deeply negative intrinsic valuation and a massive short interest. We break down the fractured technicals, pinpoint the critical options battle lines at $50 and $70, and deliver our data-backed, non-nonsense verdict. Will this technological leap be the hero that saves the stock, or is a reality check inevitable? Find out our strategic outlook and the key invalidation level that decides the war between the bulls and the bears.

Is the world's digital librarian about to lose its shelf space? Alphabet (GOOGL) is at the epicenter of an AI arms race, simultaneously securing a potential monumental cloud deal with Anthropic while facing a direct, existential threat to its core search business from a competitor's new browser. The result is a dramatic market stalemate: a long-term bullish trend facing exhausted short-term momentum and a deeply conflicted analyst community. On D-Risk, we cut through this fundamental tug-of-war, dissect the nervous options sentiment, and reveal the exact technical levels where the battle for GOOGL's immediate future will be won or lost.

D-Risk dives deep into the ultimate investor dilemma: When Texas Instruments (TXN) delivers a solid Q3 beat but issues a bombshell of soft forward guidance, which signal should you follow? We break down the massive conflict between the company's strong past performance, a startling fundamental overvaluation, and a market that went from quiet technical optimism to violent price damage overnight. Join us as we unpack the crucial battle between rewarding the past and punishing the future, dissect the exact support and resistance levels created by this shock guidance, and determine what price action will dictate the next move for the semiconductor giant.

One company in the AI space is claiming the performance of a supercar using the energy of an electric scooter, and the market just responded with an explosive 155% single-day stock surge. We're diving into GSI Technology (GSIT), a little-known chipmaker that just dropped a bombshell study showing its new tech is a potential game-changer for energy-guzzling data centers. But here's the conflict: this revolutionary technology story is colliding with an unprofitable balance sheet, creating an immense, high-stakes valuation gap. We break down the historic breakout volume, the flashing 'overbought' warning signal, and the critical price zones bulls must defend to see if this stock has a sustainable first-class ticket to the future, or if a massive short-term pullback is inevitable.

Is GE Aerospace soaring on wings of stellar earnings, or is its valuation flying too close to the sun? We dive into the explosive third-quarter results that have Wall Street cheering and dissect the fundamental conflict at the heart of the stock: a fair value estimate that's either a shocking $167 or a high-flying $383 per share, depending on the metric you trust. With the market waiting for a clear signal and technical charts showing both powerful momentum and signs of exhaustion, we cut through the noise of this deeply divided picture to reveal whether this high-altitude cruise is just beginning or if it's time to prepare for some turbulence. Tune in to D-Risk for our no-nonsense analysis and final, data-driven strategic outlook.

We’re untangling the mixed signals of telecom giant AT&T (T)! With institutional heavyweights buying in and fundamental models screaming "significantly undervalued," why is the stock chart showing signs of a messy breakdown? We dive deep into the corporate tug-of-war, from 5G wins to a costly data breach settlement, and analyze a surprisingly powerful force: an overwhelmingly bullish options market with a stampede of traders betting on a sharp bounce. Is this simply a value stock consolidating before a massive move, or is a broken long-term trend about to drag it lower? Find out the critical technical levels that determine if AT&T’s current pause is a slingshot or a slide.

Is Union Pacific's stock about to get derailed, or is it building up a new head of steam? We’re tackling the railroad giant, UNP, where a proposed $72 billion merger and overwhelmingly bullish Wall Street ratings are fighting a fierce battle against a fundamentally overvalued price and flashing red warning signs on the technical charts. The question isn't whether the company is a powerhouse, but whether the current stock price has already left the station. Tune in to see what the charts, cash flow, and options traders are telling us about the major key levels that will determine where this stock heads next.

This consumer staples giant sells everything from Tide to Charmin, but its stock chart is starting to look messy. Despite a legendary dividend streak and love from Wall Street analysts, our valuation models suggest Procter & Gamble (PG) is trading at a massive 40% premium over its calculated fair value of $107. With the overall market turning sour and options traders betting heavily against the stock (a staggering 2.82 Put-to-Call ratio), the question isn't whether this is a quality company, but whether its sterling reputation is worth the price tag. Tune into D-Risk as we break down the overwhelmingly bearish technical picture, from a sustained downtrend to signs of heavy money flowing out—to identify the critical price level that determines if PG gets flushed, or finds a long-term floor.

AMD has defied gravity, surging over 50% since July 2025 on the back of game-changing AI deals with OpenAI and Oracle. But with the stock trading at $234, nearly five times its estimated intrinsic value of $50-$55, a colossal tension is brewing. As the broader market shows signs of weakness and technical charts flash exhaustion warnings, are the bulls celebrating a new cruising altitude, or are we set for a crash landing? Tune into D-Risk for the no-nonsense analysis that dissects this high-stakes standoff and defines the critical price levels that will determine AMD's next move.

Ready to strap in for a wild ride? AI hype just sent Navitas Semiconductor (NVTS) soaring over 30%, thanks to a critical new plug-in with NVIDIA’s next-gen platforms. But before you press "buy," consider this: NVTS has a lukewarm "Hold" from professional analysts, yet is sporting a staggering 30% short interest, a classic powder keg setup for a massive short squeeze. We dive into the explosive technical breakout, the conflicting fundamental story, and the clear-as-day risks to determine if this rocket stock is set for liftoff or a sharp pullback. Don't trade another session blind; tune in to hear our Cautiously Bullish verdict and the exact price level that would invalidate the entire thesis.

The stock just blasted off to an all-time high, but is it a spectacular vision or a classic sugar rush? We’re D-Risking Bitdeer Technologies (BTDR), the crypto-miner that's making an aggressive, multi-billion-dollar pivot into AI. With the stock price now trading well above its fundamental valuation and unanimous 'Buy' ratings from analysts, the market is betting big on its future. But wait, nearly 20% of the shares are sold short, setting up a massive tug-of-war between extreme options optimism and deep-seated skepticism. Dive in to hear our verdict on this explosive technical breakout and discover the critical invalidation level that will decide if the bulls keep flying or the bears trigger a vicious short squeeze.

Bank of America ($BAC) just delivered a major earnings beat, exceeding Wall Street's expectations with stellar revenue and strong profits that fundamentally scream "buy." But before this morning's blockbuster news, the stock's chart was quietly flashing deep red, showing bearish trends, money flowing out, and a clear technical breakdown. Can a single earnings report—no matter how good—instantly invalidate a looming sector warning and wipe away the damage done by weeks of distribution? We dive into the conflicting fundamental optimism versus the technical grim reality, analyze the crowded options field at the crucial $52.50 strike, and reveal the one price level that determines if $BAC is set for a powerful breakout or if the chart's warning signs will ultimately prevail.

This semiconductor stock is facing the ultimate identity crisis: Is it a high-growth fundamental winner or a deeply troubled technical trap? Onto Innovation ($ONTO) just received a massive analyst upgrade to an almost unbelievable $180 price target, suggesting huge undervaluation. But peel back the chart, and you find a story of bearish trends, negative momentum, and a shadowy short interest actively betting against the hype. Join D-Risk as we dive into this high-stakes tug-of-war, dissect the conflicting signals in options and price action, and identify the single key level that will decide if ONTO is ready for liftoff or on the verge of a sharp crash.

Palo Alto Networks (PANW) is a fundamental fortress, celebrated by analysts with fresh 'Buy' ratings and a clear long-term trend firmly pointing up. But as the market enters a choppy, risk-off session, a massive conflict is emerging: the stock is trading at $213, yet our fair value models flag a sobering price range between $42 and $92 per share. This staggering valuation disconnect, combined with a major short interest position and cooling short-term momentum, has turned PANW into a tug-of-war between fervent bulls and entrenched skeptics. We dig into the data to find the critical $220 call options ceiling and the $208 floor that will determine whether this cybersecurity giant’s price is set for a new leg up or a reality check.

Is CrowdStrike (CRWD) the ultimate cybersecurity hero or a bubble waiting to burst? Wall Street analysts are shouting "Buy" and hiking price targets to over $500, but our cash flow model shockingly pegs the fair value at just $98 per share. Add to that a high-profile insider selling millions in stock and a nervous, risk-off market, and you have a classic high-stakes showdown. Tune in as D-Risk cuts through the noise of this tech darling's staggering valuation and mixed signals to reveal the key battleground level that will determine if the bulls or bears will win this fight.

How does the king of AI chips, Taiwan Semiconductor (TSM), balance a soaring stock price with a cold, hard valuation of less than half its current trading level? Tune into D-Risk as we dissect the ultimate high-stakes trade: TSM is riding a massive wave of AI demand and fresh, game-changing liquid cooling tech, all while preparing for a critical, record-breaking Q3 earnings report just days away. We analyze the severe technical breakdown from Friday, the bearish tilt in the options market, and the colossal expectations Wall Street has set, forcing listeners to ask: Is this stock a legendary growth story or a bubble about to pop?

This uranium stock just surged to an all-time high, fueled by a powerful growth story, a $200M war chest for expansion, and a market overwhelmingly betting on its continued rise. But when a company like Uranium Energy Corp (UEC) is trading north of $14 with a discounted cash flow fair value of just $2.25, we have to ask: Can this soaring stock defy financial gravity forever? Join D-Risk as we dissect the conflicting signals from a euphoric options market and a determined group of short sellers to determine if this high-flyer is a generational buy... or a ticking time bomb.

Will a landmark DoorDash partnership send Serve Robotics ($SERV) on an unstoppable delivery route to success, or is this the setup for a catastrophic short squeeze? This week on D-Risk, we dissect the sidewalk robot stock that just saw its price rocket by over 12% on a huge catalyst. While technicals are flashing pure upward momentum, the company's valuation is deep in the red, and a massive 24% short interest is betting on a collapse. We break down the ultimate battle between a spectacular growth narrative and a highly vulnerable balance sheet to determine if this freight train has enough steam to hold the line at $18, or if the bears are about to force a painful price reversal.

Is the AI boom creating a stock bubble? This week on D-Risk, we dive deep into IREN Limited, the former Bitcoin miner that's rocketed to a new 52-week high after an aggressive pivot to AI cloud computing. The growth story is spectacular, fueled by a massive NVIDIA GPU investment, but financial models suggest the stock is stretched to its absolute limit. We analyze the ferocious tug-of-war between bullish momentum traders and short-sellers, break down the 'overbought' technical warnings, and reveal the crucial support and resistance levels. Tune in for our Cautiously Bullish verdict on whether this AI rocket ship has enough fuel to hold its altitude, or if a sharp reality check is just around the corner.

The robots are here, and they're dividing Wall Street. UiPath (PATH) is riding a massive AI-fueled wave of partnerships with tech titans, driving a dramatic stock breakout, but is the momentum for real? We unpack the extreme conflict between a hyper-bullish options market and a huge 14.53% short interest betting on failure. Add in a surprise $1.6 million CEO stock sale and a fundamental valuation that says the stock is over $3.50 too high, and you have a high-stakes battle between powerful narrative and concerning fundamentals. Tune into D-Risk to discover the key $17.00 level the bulls must conquer to spark a short squeeze and avoid a crash.

Is Artificial Intelligence an unstoppable tailwind or an existential threat for GitLab (GTLB)? Analysts are at war, with a bullish price target of $60 on one side of the street and a downgrade due to the "severe negative impact" of AI on the other. This premium-priced DevSecOps player is caught in a market stalemate, options traders are optimistic, but a massive wall of short-sellers is betting on a fall, all while the charts flash contradictory technical signals. Tune in to D-Risk as we dissect the fundamental risks, the dramatic sentiment conflict, and the technical deadlock to determine which side will win this volatile battle before Fed Chair Powell's key address sparks the next big move.

Rocket Lab ($RKLB) is flying on escape velocity after signing landmark, multi-launch deals that cement its future revenue, yet our valuation models are flashing bright red, warning the price is already in orbit. On this episode of D-Risk, we dive into the tug-of-war between fundamental, game-changing contract wins and a critically overbought technical chart, all while a massive short interest stands ready to either cap the rally or become explosive fuel for a 'short squeeze.' Is this stock a legitimate launch to the moon backed by smart money, or an overhyped play vulnerable to a sudden crash back to Earth? Listen now to discover the critical price levels that will decide if this rocket mission continues or gets aborted.

A $75 million cash injection has sent POET Technologies ($POET) stock to a three-year high, riding a massive semiconductor tailwind, but is this the start of a multi-bagger run or a classic head-fake? The fundamentals scream "game-changer," yet the stock remains largely under the radar of big Wall Street research, creating a fascinating valuation mystery; meanwhile, a full-blown options market euphoria is fighting a tense standoff against a significant contingent of dedicated short-sellers, while the charts flash a powerful, high-volume breakout and a warning sign that the stock is dangerously stretched. Tune into D-Risk to hear our full analysis on whether this photonics innovator is poised to launch or due for a significant pullback, and discover the critical price levels that will decide the battle between bulls and bears.

A new chapter just opened for Verizon (VZ) as they installed a star CEO from the world of fintech, signaling a massive strategic pivot and potentially solving the stock's fundamental undervaluation at $41.50. While options traders are surprisingly bullish on the turnaround, the price chart has taken a dark, dramatic turn, flashing high-volume breakdowns and powerful bearish signals that scream caution. This episode of D-Risk dissects the sharp conflict between a promising new fundamental story and an "ugly" technical collapse, we'll reveal the key price levels where the bullish hopes and bearish reality will battle it out over the coming sessions.

A tiny mining stock just won the geopolitical lottery, going from "fairly valued" to a vital national asset overnight thanks to a bombshell announcement: a massive U.S. government investment and a presidential decree granting essential permits. Every prior analyst rating is now obsolete, and the market is racing to re-price this completely new reality, reflected by explosive volatility and a near-zero short interest. Join us on D-Risk as we break down the dramatic technicals and overwhelming sentiment to provide a clear strategic outlook on Trilogy Metals (TMQ)—we'll reveal the key price levels bulls must defend to confirm this game-changing shift.

A rare earth miner just went from a struggling exploration company to a geopolitical chess piece overnight! On this high-stakes episode of D-Risk, we strap in to analyze Critical Metals (CRML), a stock exploding on news of potential U.S. government backing for its critical Greenland project. We reveal the core dilemma: do you trust the abysmal negative fair value from the ugly balance sheet, or do you bet on the powerful, established uptrend and the massive wave of new capital? With 17% of the float sold short, we break down the powder keg potential for a massive squeeze and identify the single invalidation level that will tell us if this rocket is headed for the moon or a fiery crash.

A fintech rocket ship is hitting escape velocity, but the fundamentals are nowhere to be found. On this episode of D-Risk, we dive into Mercurity Fintech Holding (MFH), a stock with an astronomical valuation built on the buzzwords of AI and blockchain, not on traditional earnings. We peel back the layers to analyze the high-stakes bet being placed on this company, examining why the chart is an absolute runaway train, the options market is euphoric, and the short-sellers are sitting on a powder keg of potential. Tune in as we unmask the core conflict between a compelling narrative and a price deep in "overbought" territory to determine the critical level that will decide if this parabolic rally is just a brilliant story or a pending catastrophe.

Can the gatekeeper of financial identity survive when its key partner attacks its business model? Equifax (EFX) just got handed a failing grade by the market after FICO launched a direct assault on the lucrative mortgage scoring business, shattering the stock's chart on a stampede of selling volume. We dive into the massive chasm between bullish Wall Street analysts and a free cash flow valuation that hints at deep trouble. Why are options traders betting on a massive bounce despite the technical breakdown, and what critical price level must Equifax reclaim to signal the worst of the panic is over? Tune in to D-Risk to discover the true stakes of this fundamental war and our final, cautious verdict.

When the company that judges your credit score gets its own credit line cut by the market, you know it’s time to pay attention. TransUnion (TRU) was absolutely hammered after a rival launched a surgical strike against its core revenue stream, leading to a catastrophic stock crash that the market didn't see coming. Join D-Risk as we dissect the classic David vs. Goliath battle, examining the disconnect between a deeply oversold stock, aggressive short sellers, and the surprisingly optimistic options traders betting on a bounce. We break down the technical failure across the board and reveal the critical invalidation level that will determine if this credit giant has any chance of recovery, or if the pain has just begun.

Can a single conversation with the White House send a stock soaring? They say don't mix politics with your portfolio, but this week, USA Rare Earth (USAR) proves some chats are worth a fortune! As the stock rockets past analyst targets on strategic government talks and a massive acquisition—all while carrying zero revenue—we dig deep into the high-stakes bet being placed on America's critical mineral supply chain. We uncover the twist of overwhelming bullish options activity battling a double-digit short interest and break down the "overheated" technicals that show a stampede of buying pressure. Tune in to D-Risk to discover the precise price levels that bulls must defend, the key invalidation level for this explosive rally, and our final, cautious verdict on where this critical stock is headed next.

Clean energy player Stem (STEM) is a high-stakes poker game: the company just made a major strategic pivot to high-margin software, creating a forward-looking bullish narrative, but is that enough to justify its "Overvalued" status? This episode of D-Risk dives into the epic conflict between pure market optimism and hard numbers. We track the technical story, which shows the price, volume, and momentum are aligned for a powerful push toward recent highs, while simultaneously grappling with two major threats: a large 13.81% short interest betting on a crash and a unanimous "Hold" rating from Wall Street analysts. With a government shutdown adding macro jitters, can the bulls hold the line at critical support levels, or is the new software story a temporary distraction before the bears take control? Tune in to get our full breakdown on the key price levels that will determine the outcome.

Is Fluence Energy (FLNC) a screaming Buy or a spectacular Trap? After the grid battery stock surged over 24% on news of a major shareholder merger talk and an operational breakthrough with their new Smartstack system, the market is betting big on its future. But behind the bullish technicals, a soaring trend and massive conviction volume, lies a dangerous conflict: the stock is currently trading nearly $8 above its core fundamental fair value, while an army of short sellers holds a massive 33.88% short interest. This episode of D-Risk dives into the core conflict: is the stock's explosive momentum and huge short interest the perfect fuel for a massive short squeeze toward $14, or is the overvalued stock primed for a crash back to its $10 breakout zone? Tune in to get our full strategic outlook and key price levels to watch.

Is Warren Buffett's nine-point-seven-billion-dollar cash injection for Occidental Petroleum (OXY) the ultimate buy signal, or is Wall Street right to collectively shrug? In an economic climate fraught with contradictions—from booming GDP to a government shutdown—OXY is trading at a deep discount, with fair value estimates soaring over 100% higher than its current price. We dive into the massive debt-slashing deal, the aggressively bullish options market, and the long-term technical trend that suggests a major move is on the horizon, yet nearly 71% of analysts are still saying "Hold." Tune in to find out why the Oracle of Omaha's stamp of approval is facing a wall of indifference, and whether the battle for the crucial $50 level will unleash the next big rally for this energy giant.

They said "Just Do It," but investors were left asking "Do what?" after Nike (NKE) delivered a classic surprise quarter that sent the stock soaring! On this episode of D-Risk, we lace up for a no-nonsense analysis of the earnings sprint, which saw revenue beat expectations and sparked a massive after-hours rally. But before you buy the hype, look closer: net income fell 31% and margins are squeezed. Is this a genuine turnaround fueled by a strategic pivot, or just a sugar high masking deeper profitability problems? We dissect the bullish options action, the critical oversold technical signals, and the exact price levels that will determine if the athletic giant is ready for a new marathon or just a short-lived dash. Tune in to hear our final strategic outlook and the key price point where the bulls lose the race.

What happens when a critical minerals company gets the ultimate seal of approval from Uncle Sam? Today on D-Risk, we dive into Lithium Americas (LAC) after a direct U.S. government equity investment and a massive restructured federal loan sent the stock price soaring. It's a classic Wall Street showdown: a game-changing, de-risking catalyst against a backdrop of a nervous market, cautious "Hold" analyst ratings, and a pre-revenue balance sheet. We cut through the noise, analyzing the explosive technical breakout, the bullish options market, and the colossal short interest that could send the stock into a short squeeze. Will the government's vote of confidence be enough to defy the market's skepticism? Tune in for the full, no-nonsense strategic outlook.

Will a massive government deal be the cure for Pfizer's (PFE) sluggish stock performance? The pharmaceutical giant just pulled a strategic masterstroke, insulating itself from a crippling new industry headwind with a landmark $70 billion domestic investment. But while options traders are screaming "bullish," the underlying fundamentals show a complicated story with an alarming revenue problem. Join D-Risk as we dissect this trade, weigh the game-changing political maneuver against the cautious analyst ratings, and use technicals to find the critical price levels that will determine if this stock is due for a powerful breakout or a false alarm.

Can a stock surge 1,700% in a single day and still be a sell? On this episode of D-Risk, we dissect Wolfspeed (WOLF), the semiconductor company that just completed a court-approved corporate rebirth, shedding 70% of its debt and releasing a new product. But this phoenix is flying into a storm: a stunning 50%+ short interest and half of Wall Street analysts flashing 'Strong Sell' are battling a technical chart that looks like a volcanic eruption. Tune in as we cut through the noise of yesterday's massive short squeeze to establish the critical price levels that determine if this move is a sustainable recovery or an overbought rally destined to crash back to earth.

Is this rental giant a dirt-cheap bargain, or a financial breakdown waiting to happen? On this episode of D-Risk, we crash-test Hertz (HTZ), a stock where one fundamental model suggests a value over $90, yet another screams zero. While the company secures major financing, every Wall Street analyst says 'Hold' or 'Sell,' and the stock is caught in a dramatic civil war: hyper-bullish options traders are battling a colossal 43% short-interest. Tune in as we dissect the extreme polarization in this stock's story and pinpoint the critical $7.00 and $6.00 levels that will determine its next explosive move.

Is Etsy's massive AI partnership a revolutionary leap, or a classic case of speculative hype? On this episode of D-Risk, we dive deep into ETSY, where a game-changing deal with ChatGPT is running headlong into a valuation gap you could drive a truck through. While technical charts scream "Buy" and options traders are overwhelmingly bullish, a staggering 28% short interest creates a powder keg, and a discounted cash flow model suggests the stock is profoundly overvalued. Tune in as we weigh the explosive technical momentum against alarming fundamental risks to deliver a strategic outlook on whether the AI-powered future can truly justify today's sky-high price.

Lockheed Martin ($LMT) is a defense powerhouse swimming in a $20 billion contract boom, but is the stock flying too high? While technicals show a forceful rally and strong institutional buying, our valuation models suggest the price is trading at a significant premium to its fair value. We reveal the split between skeptical Wall Street analysts, who overwhelmingly rate it a "Hold," and options traders who are bracing for volatility. Tune in to D-Risk as we break down this overbought chart to find the key price level, a floor defended by millions in options bets, that will determine if this aerospace giant is cleared for a continued ascent or if it's due for a dramatic, profit-taking correction.

Bristol-Myers Squibb ($BMY) is facing a classic "value trap" dilemma: cash flow models scream a fair price near $97 a share, yet the stock trades around $44. We dive into the massive disconnect fueled by deep R&D cuts and a bearish technical trend, which has 73% of Wall Street analysts stuck on the sidelines with a "Hold" rating. But don't look away, bullish options traders are placing heavy bets on a reversal from oversold territory. Tune in to D-Risk as we break down the conflicting signals to reveal the key price level that will determine if this pharma giant is a bargain bin treasure or a falling knife that's about to bounce.

Ford ($F) just unveiled a massive new EV plan, promising a game-changing $30,000 electric truck by 2027, but Wall Street's "Hold" rating suggests analysts aren't ready to shift gears. Dive into this fascinating disconnect as we reveal why multiple valuation models scream "undervalued," dissect a strongly bullish options market, and break down the technical breakout that has the stock accelerating. Will the prospect of affordable EVs finally light a fire under this classic automaker? Tune in to D-Risk to find out which key price level bulls must conquer to put the skepticism in the rearview mirror!

Is Wolfspeed (WOLF) a phoenix rising from the ashes of bankruptcy or a dying star heading for a black hole? This episode of D-Risk dives into the high-stakes drama of the silicon carbide semiconductor specialist, whose stock just plummeted over 20% pre-market despite a recent court approval of its debt-slashing reorganization plan. The fundamentals are a chaotic mess, with analyst "fair value" estimates swinging from a lofty $29 to a negative valuation, and a jaw-dropping 51% of the available shares sold short. We strip away the noise to dissect the technical carnage, analyzing the decisive breakdown below key support and the overwhelming bearish conviction from professional skeptics, to determine if this flash crash is a final capitulation or the violent start of a potential, face-ripping short squeeze that could ignite on any flicker of good news.

Is the scorching rally in Centrus Energy (LEU) a rocket ship riding the nuclear renaissance or a volatile roman candle set to fizzle? The stock is white-hot following a bombshell multi-billion-dollar expansion plan for its U.S. uranium enrichment plant, perfectly timed for a global market where uranium prices are soaring and demand is forecast to jump 28% by 2030. However, the stock closed yesterday at $312, a staggering premium to its $189 fair value, igniting a fierce battle between giddy options bulls and a massive crowd of short-sellers who have piled into a whopping 20.67% of the float. With the technical trend screaming bullish, yet flashing "overextended," we cut through the noise to dissect this high-stakes tension between fundamental transformation, extreme valuation, and the growing risk of an explosive short squeeze.

Is Datavault AI's $150 million Bitcoin-funded supercomputer strategy a game-changer, or is its money-losing past too heavy a burden? This episode of D-Risk dives into the high-stakes battle over ticker DVLT, where the market is cheering a spectacular, forward-looking catalyst while the company's intrinsic worth still whispers a mere $0.33 per share. With short-sellers betting against the stock's explosive breakout and technical indicators flashing "overbought," we analyze whether a powerful short squeeze is about to ignite or if fundamental gravity will pull the price back to earth. Join us for a no-nonsense analysis of DVLT's technical trends, valuation disconnect, and market sentiment.

AI darling Astera Labs (ALAB) was one of the market's highest flyers, but what happens when giants like Intel and Nvidia threaten to step on its turf? A sudden 10% plunge has turned this stock into a major battleground, pitting bullish Wall Street analysts against a starkly bearish reality: its cash-flow valuation is a mere $17, yet it trades for over $200. With the technical charts confirming a violent, high-volume breakdown and short-sellers smelling blood, the central question is urgent. In this episode, we dissect the data to determine if this is a golden buying opportunity or the beginning of a catastrophic collapse for a massively overvalued company.

What happens when a biotech company announces a potential miracle cure and, mere hours later, hands the market a $100 million bill? That's the complex diagnosis facing PepGen (PEPG) after a bombshell clinical trial announcement sent its stock exploding upwards on stampede-like volume, only to be followed by a massive, dilutive share offering. With a significant number of traders betting against it and a chart screaming both "breakout" and "dangerously overbought," the stock is now a major battleground. In this episode, we dissect the conflict between groundbreaking science and financial reality to determine if this explosive rally has a healthy prognosis or if it's just a flash of market fever destined to fade.